North America Drug Delivery Devices Market By Route Of Administration(Oral Drug Delivery, Pulmonary Drug Delivery, Inject Able Drug Delivery , Ocular Drug Delivery , Nasal Drug Delivery, Topical Drug Delivery , Implantable Drug Delivery , Tran Mucosal Drug Delivery) By Facility Of Use (Hospitals, Ambulatory Surgical Centers, Home Care Settings, Diagnostic Centers, Other) – Industry Analysis, Size, Share, Growth, Trends, And Forecasts(2016–2021)

North America Drug Delivery Devices Market By Route Of Administration(Oral Drug Delivery, Pulmonary Drug Delivery, Inject Able Drug Delivery , Ocular Drug Delivery , Nasal Drug Delivery, Topical Drug Delivery , Implantable Drug Delivery , Tran Mucosal Drug Delivery) By Facility Of Use (Hospitals, Ambulatory Surgical Centers, Home Care Settings, Diagnostic Centers, Other) – Industry Analysis, Size, Share, Growth, Trends, And Forecasts(2016–2021)

ID: 2347 | Pages: 180 | May 2017 | Region: North America


The North America market for Drug Delivery Technology is expected to reach USD 599.94 billion by 2021 from USD 448.10 billion in 2016 at a CGAR 6.01% during forecast period.

The U.S. is predicted to keep on dominating the market amid the estimate time frame. The substantial share of the U.S. in the North American market can fundamentally be credited to variables, for example, the rising pervasiveness of chronic infections; fast development in the geriatric population; development in the biologics ; and expanding number of administrative endorsements, new item dispatches, and mechanical progressions.

Drug delivery market can be segmented on the basis of Route of administration and facility of use. On the basis of route of administration, Market can be segmented into Oral Drug Delivery, Pulmonary Drug Delivery, Inject able Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Tran mucosal Drug Delivery. Oral Drug delivery is sub segmented into Solid Oral Drugs, Liquid Oral Drugs, and Semi-solid Oral Drugs. Pulmonary Drug delivery is sub segmented into Formulations and Devices. Inject able Drug delivery can be segmented into devices and formulations. Self-Injection devices are further segmented into Needle-Free Injectors, Auto injectors, Pen injectors, Wearable Injectors. Ocular delivery devices are segmented into Formulation and ocular devices. Nasal Drug delivery is segmented into Nasal Drops, Nasal Sprays, Nasal Powders and Nasal Gels. Tropical Drug Delivery is segmented by formulations and devices. Implantable Drug delivery is segmented by Active and passive. Tran mucosal Drug Delivery is segmented into oral Tran mucosal Drug Delivery and other Tran mucosal Drug Delivery. On the basis of Administration Market can be segmented as Hospitals, Ambulatory Surgical Centers, Home Care settings, Diagnostic Centers, Other Facilities of Use.

Some of the key players in the market are, Bend Research, Endocyte, Microchips Inc, Pearl Therapeutics Inc, Presage Bioscience, UCB Group, Genentech Inc, Polymer Factory, Alkermes Inc, BIND Biosciences Inc, and QLT Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Route of administration                        

                                5.1.1 Introduction           

                                5.1.2 Oral Drug Delivery

                                5.1.3 Pulmonary Drug Delivery  

                                5.1.4 Inject able Drug Delivery   

                                5.1.5 Ocular Drug Delivery           

                                5.1.6 Nasal Drug Delivery             

                                5.1.7 Topical Drug Delivery          

                                5.1.8 Implantable Drug Delivery                

                                5.1.9 Tran mucosal Drug Delivery             

                                5.1.10  Y-o-Y Growth Analysis, By Route of administration            

                                5.1.11  Market Attractiveness Analysis, By Route of administration          

                                5.1.12  Market Share Analysis, By Route of administration            

                5.2 Facility of use                             

                                5.2.1 Introduction           

                                5.2.2 Hospitals  

                                5.2.3 Ambulatory Surgical Centers           

                                5.2.4 Home care settings             

                                5.2.5 Diagnostic Centers               

                                5.2.6 Others      

                                5.2.7 Y-o-Y Growth Analysis, By Facility of use    

                                5.2.8 Market Attractiveness Analysis, By Facility of use  

                                5.2.9 Market Share Analysis, By Facility of use    

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 Route of administration

                                                6.1.3.3 By Facility of use

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Route of administration

                                                6.1.4.3 By Facility of use

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Route of administration

                                                6.1.5.3 By Facility of use

                6.2 United States                            

                6.3 Canada                         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Bend Research                          

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Endocyte                     

                8.3 MicroCHIPS Inc                         

                8.4 Pearl Therapeutics Inc                           

                8.5 Presage Bioscience                 

                8.6 UCB Group                 

                8.7 Genentech Inc                          

                8.8 Polymer Factory                       

                8.9 Alkermes Inc                              

                8.10 BIND Biosciences Inc                            

                8.11 QLT Inc                       

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organisations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. North America Drug Delivery Devices Market By Route of administration , From 2016-2021 ( USD Million )
  2. North America Oral Drug Delivery Market By Region, From 2016-2021 ( USD Million )
  3. North America Pulmonary Drug Delivery Market By Region, From 2016-2021 ( USD Million )
  4. North America Injectable Drug Delivery  Market By Region, From 2016-2021 ( USD Million )
  5. North America Ocular Drug Delivery  Market By Region, From 2016-2021 ( USD Million )
  6. North America Nasal Drug Delivery Market By Region, From 2016-2021 ( USD Million )
  7. North America Topical Drug Delivery  Market By Region, From 2016-2021 ( USD Million )
  8. North America Implantable Drug Delivery  Market By Region, From 2016-2021 ( USD Million )
  9. North America Tran mucosal Drug Delivery Market By Region, From 2016-2021 ( USD Million )
  10. North America Drug Delivery Devices Market By Facility of use, From 2016-2021 ( USD Million )
  11. North America Hospitals Market By Region, From 2016-2021 ( USD Million )
  12. North America Ambulatory Surgical Centers Market By Region, From 2016-2021 ( USD Million )
  13. North America Home Care settings Market By Region, From 2016-2021 ( USD Million )
  14. North America Diagnostic Centers Market By Region, From 2016-2021 ( USD Million )
  15. North America Others Market By Region, From 2016-2021 ( USD Million )
  16. United States Drug Delivery Devices Market By Route of administration , From 2016-2021 ( USD Million )
  17. United States Drug Delivery Devices Market By Facility of use, From 2016-2021 ( USD Million )
  18. Canada Drug Delivery Devices Market By Route of administration , From 2016-2021 ( USD Million )
  19. Canada Drug Delivery Devices Market By Facility of use, From 2016-2021 ( USD Million )
Middle East And Africa Hernia Mesh Devices Market By Hernia Type (Inguinal, Incisional, Femoral, Umbilical), By Product Type (Synthetic Mesh, Biologic Mesh), And By Region – Middle-East And Africa Industry Analysi...
Latin America Hernia Mesh Devices Market By Hernia Type (Inguinal, Incisional, Femoral, Umbilical), By Product Type (Synthetic Mesh, Biologic Mesh), And By Region – Latin America Industry Analysis, Size, Share, Gr...
Asia-Pacific Hernia Mesh Devices Market By Hernia Type (Inguinal, Incisional, Femoral, Umbilical), By Product Type (Synthetic Mesh, Biologic Mesh), And By Region – Asia-Pacific Industry Analysis, Size, Share, Grow...
Europe Hernia Mesh Devices Market By Hernia Type (Inguinal, Incisional, Femoral, Umbilical), By Product Type (Synthetic Mesh, Biologic Mesh), And By Region - Europe Industry Analysis, Size, Share, Growth, Trends, An...
North-America Hernia Mesh Devices Market By Hernia Type (Inguinal, Incisional, Femoral, Umbilical), By Product Type (Synthetic Mesh, Biologic Mesh), And By Region – North America Industry Analysis, Size, Share, Gr...
Hernia Mesh Devices Market By Hernia Type (Inguinal, Incisional, Femoral, Umbilical), By Product Type (Synthetic Mesh, Biologic Mesh), And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forec...
Middle East And Africa Parkinson’s Disease Treatment Market By Drug Class (Dopamine Receptor Antagonists, Mono Amine Oxidase Inhibitors, Carbidopa, Anticholinergics And Other Drug Classes), By Distribution Channel...
Latin America Parkinson’s Disease Treatment Market By Drug Class (Dopamine Receptor Antagonists, Mono Amine Oxidase Inhibitors, Carbidopa, Anticholinergics And Other Drug Classes), By Distribution Channel (Retaile...
Asia Pacific Parkinson’s Disease Treatment Market By Drug Class (Dopamine Receptor Antagonists, Mono Amine Oxidase Inhibitors, Carbidopa, Anticholinergics And Other Drug Classes), By Distribution Channel (Retailer...
Europe Parkinson’s Disease Treatment Market By Drug Class (Dopamine Receptor Antagonists, Mono Amine Oxidase Inhibitors, Carbidopa, Anticholinergics And Other Drug Classes), By Distribution Channel (Retailer Pharm...
North America Parkinson’s Disease Treatment Market By Drug Class (Dopamine Receptor Antagonists, Mono Amine Oxidase Inhibitors, Carbidopa, Anticholinergics And Other Drug Classes), By Distribution Channel (Retaile...
Parkinson’s Disease Treatment Market By Drug Class (Dopamine Receptor Antagonists, Mono Amine Oxidase Inhibitors, Carbidopa, Anticholinergics And Other Drug Classes), By Distribution Channel (Retailer Pharmacies, ...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.